<DOC>
	<DOCNO>NCT01641445</DOCNO>
	<brief_summary>This study help determine whether medication , topiramate , reduces alcohol use among adolescent alcohol dependence . It also help answer question , `` How topiramate reduce drink teenager ? '' Understanding topiramate may reduce drinking adolescent would allow target pharmacotherapeutic approach treatment help identify additional medication may hold promise improve treatment outcome youth .</brief_summary>
	<brief_title>Effects Topiramate Adolescent Alcohol Use : Efficacy Mechanisms</brief_title>
	<detailed_description>Adolescent alcohol use associate myriad adverse legal , health , educational consequence contribute leading cause mortality among youth . Yet despite magnitude public health problem , treatment initiative youth remain inadequate . Given data , National Institute Alcohol Abuse Alcoholism identify critical need medication development research youth goal identify promising agent large-scale clinical trial justify . The long-term goal research program improve pharmacotherapy alcoholism . The major objective project address urgent need empirical data medication may benefit youth . For past 10 year research program successfully pair human laboratory paradigm ecological momentary assessment ( EMA ) , whereby research participant use handheld electronic diary monitor drinking , craving , sensitivity alcohol real time natural environment . Using approach , identify mechanism medication act patient characteristic moderate effect . The propose study test topiramate ( TPM ) , anticonvulsant show efficacious treat adult , reduces drink youth . To end , randomize adolescent problem drinker TPM placebo 8 week , combination biweekly motivational enhancement therapy session , use two-group , double-blind design . While target dose ( 200 mg/day ) youth complete EMA natural environment . In addition , youth complete alcohol cue reactivity assessment laboratory test effect TPM cue-elicited crave physiological reactivity control environment . Youth complete 6- 12-month follow-up assessment determine whether benefit sustain . This study provide much need data tolerability efficacy TPM adolescent , add important new information biobehavioral mechanism TPM action youth .</detailed_description>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Underage Drinking</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>1424 year old ( inclusive ) Nontreatment seek alcohol abuse dependence Interest reduce alcohol use Selfreported alcohol use least 2 days/week prior 28 day Able read simple English Alcohol substance abuse treatment past 30 day Clinically significant medical abnormality History renal impairment , renal stone , unstable hypertension History progressive neurodegenerative disorder clinical significant neurological disorder Body mass index lower 18 Pregnant , nursing , refusal use reliable birth control , female Nonstabilized psychotropic medication and/or take medication contraindicate use topiramate Medications may effect alcohol use carbonic anhydrase inhibitor Suicidal psychotic Current coexisting substance use disorder alcohol , caffeine , cannabis , nicotine use disorder Clinically significant alcohol withdrawal symptom Impaired cognitive function Living active study participant Compelled treatment juvenile justice system</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>